CMS Research Policy May Deny Coverage For Hundreds Of Device Trials
This article was originally published in The Gray Sheet
Executive Summary
CMS' proposed Clinical Research Policy has generated widespread concern within the device industry about its potential to restrict Medicare support for clinical trials